We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Léčba roztroušené sklerózy perorálním kladribinem.
- Authors
Ampapa, Radek; Dufek, Michal; Hradílek, Pavel; Kovářová, Ivana; Mareš, Jan; Martinková, Alena; Peterka, Marek; Štourač, Pavel; Tvaroh, Aleš; Vachová, Marta; Vališ, Martin
- Abstract
Oral cladribine is a high efficacy disease-modifying drug for treatment of multiple sclerosis. Its mode of action represents a selective immune-reconstitution resulting in simply dosing in two annual curses followed by a sustained period of a potential remission. Our work is aimed to an initiation of oral cladribine treatment, monitoring schedule and types of terapeutic response. Consequent treatment options are suggested based on eventual disease activity after cladribine courses. Furthermore, cladribine is discussed from perspective of pregnancy planning and vaccination.
- Publication
Neurologie Pro Praxi, 2021, Vol 22, Issue 3, p226
- ISSN
1213-1814
- Publication type
Article